Emergent BioSolutions Inc. — Director's Dealing 2017

Sep 30, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-09-27

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-27	Common Stock	M	1266	$7.99	Acquired	24676	Direct
2017-09-27	Common Stock	S	1266	$40.00	Disposed	23410	Direct
2017-09-28	Common Stock	M	22415	$7.99	Acquired	45825	Direct
2017-09-28	Common Stock	S	22415	$40.00	Disposed	23410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-27	Employee Stock Option (Right to buy)	$7.99	M	1266	Disposed	2018-05-21	Common Stock (1266)	Direct
2017-09-28	Employee Stock Option (Right to buy)	$7.99	M	22415	Disposed	2018-05-21	Common Stock (22415)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive.

F3: Consists of an option granted under the company's stock incentive plan as amended and restated.

F4: The option grant is fully vested.